Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Ocul Immunol Inflamm ; 30(6): 1369-1377, 2022 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-33793375

RESUMO

PURPOSE: The aim is to unravel the mechanism of mesalazine (5-ASA) on proinflammatory cytokines in PBMCs of patients with HLA-B27 +and HLA-B27 -acute anterior uveitis (AAU), and whether this may explain the different effects of 5-ASA in both disoders. METHODS: PBMCs from 12 HLA-B27+ and 4 HLA-B27- AAU patients were preincubated with 5-ASA and stimulated with LPS. As mesalazine (5-ASA) could be involved in ER stress, proinflammatory and ER stress-associated cytokines and markers were measured. RESULTS: Mesalazine (5-ASA) suppressed IL-6 mRNA in healthy donors and in HLA-B27+ and HLA-B27- patients but did not lead to induction and secretion of IL-1ß. In HLA-B27 + or - patients the ER stress-associated markers CHOP (DDIT3) and ATF6 were suppressed. CONCLUSIONS: Here we show that mesalazine (5-ASA) inhibits the transcription of proinflammatory and (ER) stress associated cytokines and markers, independently of the HLA-B27 status. Results show the similarities of both AAU types but do not decipher the mechanism why the HLA-B27 status determines the therapeutic response to mesalazine in AAU.


Assuntos
Antígeno HLA-B27 , Uveíte Anterior , Humanos , Antígeno HLA-B27/genética , Mesalamina/farmacologia , Mesalamina/uso terapêutico , Citocinas/genética , Uveíte Anterior/tratamento farmacológico , Uveíte Anterior/genética , Doença Aguda
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA